World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
31299
World Ranking
14475
National Ranking
7321

Overview

Richard C. Shelton is affiliated with the University of Alabama at Birmingham in the United States. Their research spans primarily the fields of Medicine and Neuroscience, with a significant focus on subfields such as Pharmacology, Biological Psychiatry, Psychiatry and Mental Health, Clinical Psychology, and Cognitive Neuroscience.

The scientist's main topics of study include:

  • Treatment of Major Depression
  • Tryptophan and brain disorders
  • Bipolar Disorder and Treatment
  • Functional Brain Connectivity Studies
  • Stress Responses and Cortisol
  • Mental Health Research Topics
  • Transcranial Magnetic Stimulation Studies

Richard C. Shelton has published extensively with several frequent coauthors, including Matthew Macaluso, George I. Papakostas, Madhukar H. Trivedi, Manish K. Jha, and Maurizio Fava.

The scientist's recent publications include:

  • "A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials," 2021, Molecular Psychiatry
  • "Strong associations of telomere length and mitochondrial copy number with suicidality and abuse history in adolescent depressed individuals," 2023, Molecular Psychiatry
  • "Obesity, inflammation, and depression in adolescents," 2023, Frontiers in Psychiatry
  • "Double-Blind, Placebo-Controlled, Proof-Of-Concept Trial of a Kappa-Selective Opioid Receptor Antagonist Augmentation in Treatment-Resistant Depression," 2020, Annals of Clinical Psychiatry
  • "The effect of IV ketamine in patients with major depressive disorder and elevated features of borderline personality disorder," 2022, Journal of Affective Disorders

Key publication venues for their work include:

  • Journal of Affective Disorders
  • Molecular Psychiatry
  • Frontiers in Psychiatry
  • Annals of Clinical Psychiatry
  • International Journal of Bipolar Disorders

In addition to journal articles, Shelton has contributed to book publications, such as "Drug Development in Psychiatry," published by Springer International Publishing in 2023.

Best Publications

  • Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis

    Jay C. Fournier;Robert J. DeRubeis;Steven D. Hollon;Sona Dimidjian

  • Cognitive therapy vs medications in the treatment of moderate to severe depression.

    Robert J. DeRubeis;Steven D. Hollon;Jay D. Amsterdam;Richard C. Shelton

  • Prevention of relapse following cognitive therapy vs medications in moderate to severe depression.

    Steven D. Hollon;Robert J. DeRubeis;Richard C. Shelton;Jay D. Amsterdam

  • A novel augmentation strategy for treating resistant major depression.

    Richard C. Shelton;Gary D. Tollefson;Mauricio Tohen;Stephen Stahl

  • Effort-Based Decision-Making in Major Depressive Disorder: A Translational Model of Motivational Anhedonia

    Michael T. Treadway;Nicholas A. Bossaller;Richard C. Shelton;David H. Zald

  • Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study

    Vanina Popova;Ella J. Daly;Madhukar Trivedi;Kimberly Cooper

  • Efficacy and Safety of Intranasal Esketamine Adjunctive to Oral Antidepressant Therapy in Treatment-Resistant Depression: A Randomized Clinical Trial

    Ella J. Daly;Jaskaran B. Singh;Maggie Fedgchin;Kimberly Cooper

  • Effectiveness of St John's wort in major depression: A randomized controlled trial

    Richard C. Shelton;Martin B. Keller;Allan Gelenberg;David L. Dunner

  • Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression: A Randomized Clinical Trial.

    Ella J. Daly;Madhukar H. Trivedi;Adam Janik;Honglan Li

  • A Double-Blind, Randomized, Placebo-Controlled, Dose-Frequency Study of Intravenous Ketamine in Patients With Treatment-Resistant Depression

    Jaskaran B. Singh;Maggie Fedgchin;Ella J. Daly;Peter De Boer

  • Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression

    R C Shelton;J Claiborne;M Sidoryk-Wegrzynowicz;R Reddy

  • Functional Biomarkers of Depression: Diagnosis, Treatment, and Pathophysiology

    Heath D Schmidt;Richard C Shelton;Ronald S Duman

  • Combining Medications to Enhance Depression Outcomes (CO-MED): Acute and Long-Term Outcomes of a Single-Blind Randomized Study

    A. John Rush;Madhukar H. Trivedi;Jonathan W. Stewart;Andrew A. Nierenberg

  • Prediction of Response to Medication and Cognitive Therapy in the Treatment of Moderate to Severe Depression

    Jay C. Fournier;Robert J. DeRubeis;Richard C. Shelton;Steven D. Hollon

  • Personality change during depression treatment: a placebo-controlled trial.

    Tony Z. Tang;Robert J. DeRubeis;Steven D. Hollon;Jay Amsterdam

  • Cognitive therapy and pharmacotherapy for depression.

    Steven D. Hollon;Richard C. Shelton;Peter T. Loosen

  • Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

    George I. Papakostas;Michael E. Thase;Michael E. Thase;Maurizio Fava;J. Craig Nelson

  • Comorbid psychiatric disorders in depressed outpatients: Demographic and clinical features

    A. John Rush;Mark Zimmerman;Stephen R. Wisniewski;Maurizio Fava

  • Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.

    George I. Papakostas;Richard C. Shelton;Juliana Smith;Maurizio Fava

  • L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials.

    George I. Papakostas;Richard C. Shelton;John M. Zajecka;Bijan Etemad

Frequent Co-Authors

Michael E. Thase
Michael E. Thase University of Pennsylvania
Madhukar H. Trivedi
Madhukar H. Trivedi The University of Texas Southwestern Medical Center
Maurizio Fava
Maurizio Fava Harvard University
William V. Bobo
William V. Bobo Mayo Clinic
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Steven D. Hollon
Steven D. Hollon Vanderbilt University
Edward S. Friedman
Edward S. Friedman University of Pittsburgh
Mauricio Tohen
Mauricio Tohen University of New Mexico
George I. Papakostas
George I. Papakostas Harvard University
Thilo Deckersbach
Thilo Deckersbach Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The journey to a medical career in the USA is diverse, and online degrees now offer greater flexibility for students and professionals. Several online degree pathways complement or extend your medical and healthcare studies, making advanced roles more accessible while balancing work and personal commitments.

For those interested in healthcare administration, earning a degree from one of the cahme accredited programs ensures the highest standards for online master's in health administration. Nursing professionals can progress with options such as the rn to bsn online without clinicals, designed for working nurses seeking advancement without additional in-person clinical requirements.

For those aiming for the highest level of nursing practice, consider the fastest dnp program to accelerate your career growth. Additionally, students who prefer less-intensive research requirements may be interested in accredited dnp programs without dissertation. Each of these online pathways broadens career possibilities and offers non-traditional students greater control over their professional futures in healthcare.

Best Scientists Citing Richard C. Shelton

Trending Scientists

Recently Published Articles